In the high-velocity world of hedge funds, where quarterly performance often determines survival, BlueBalance Capital has built its reputation on an almost heretical principle: waiting. The Vienna-based firm, which manages €400m across two funds, has spent 15 years perfecting what Co-Founder Michael Schülli describes as “investing into dislocations, rather than trading derivatives.”
The strategy emerged from an unlikely birthplace – the balance sheet of one of Austria’s largest insurers, where the team was tasked with creating an unconstrained book that could generate returns independent of the company’s benchmark-driven allocations. The brief was simple: small risks, maximum diversification, and absolutely no large drawdowns that could hurt the conservative insurance giant.
What evolved was a discretionary approach to harvesting “abnormal term structures” – pricing dislocations across derivatives markets that occur when expectations overshoot, structural flows create imbalances, or trading book constraints distort normal relationships. Rather than forecasting market direction, the team hunts for parameters trading at statistical extremes, typically above the 90th percentiles, then waits for mean reversion.
The approach is deliberately contrarian. Whilst most hedge funds focus on monthly performance, BlueBalance targets 12-24 month holding periods for individual trades. This longer horizon, the team argues, dramatically increases the probability of success whilst reducing competition from multi-strategy platforms that must report quarterly returns.
“We can wait until the dislocation monetises,” explains Schülli, whose fund maintained an average holding period of 15-18 months in 2024. “This is what many funds cannot afford, because they need to have certainty when the trade will materialise.”
The approach delivered a 7.70% return in 2024 after 14.05% in 2023 with a Sharpe ratio of 1.31 (and 2.61 respectively), maintaining positive performance in nine of twelve months despite a volatile year. More tellingly, the fund’s 60-90 concurrent positions maintain an average pairwise correlation near zero – a level of diversification approaching the theoretical minimum.
This diversification extends beyond traditional asset classes. The team dissects equity, rates, and foreign exchange markets into constituent risk factors – volatility, correlation, skew, basis relationships – then constructs trades that isolate specific opportunities. A position might capture the difference between individual stock movements and their broader index, exploit pricing gaps between clearing houses, or profit from unusual relationships between currency pairs.
One of the fund’s top performer in 2024 exemplified this approach: a rates clearing basis trade between Eurex and LCH exchanges that captured a mundane but profitable dislocation in how identical interest rate instruments were priced across different venues. Such opportunities, Schülli notes, often emerge from structural constraints rather than fundamental market views.
“We are always earning carry, but not forecasting market direction,” he explains. “We are always true to our philosophy, but we evolve and adjust with the market.”
The strategy’s insurance heritage remains embedded in its construction. A constant hedging component protects against systemic stress, sourced from attractively priced long-volatility opportunities rather than simple index puts. This defensive overlay contributed 1.04% to returns in 2024, demonstrating the fund’s ability to find capital-efficient hedges that provide protection without a significant drag on performance.
Technology plays a central role – not for generating trading signals, but for screening markets to identify where dislocations might lurk. The proprietary models flag unusual curve shapes or extreme correlations, which the team then analyses to understand the underlying structural reasons.
This technological infrastructure supports relationships with 11 tier-one banks, granting access to over-the-counter structures that remain beyond the reach of most funds. The access is crucial: many of the dislocations BlueBalance targets exist only in bespoke derivatives markets where banks can structure precise exposures to isolated risk factors.
“Each bank has its strengths,” notes Schülli. “Some excel in interest rates, whilst others are stronger in equities. We leverage these strengths to build strong, long-term relationships.”
The approach faces natural capacity constraints. The team estimates the strategy could absorb up to €2bn before liquidity constraints or market impact began degrading returns. For now, maintaining nimbleness remains a priority.
The fund operates a second vehicle, a UCITS fund that follows the same philosophy with a return target of EUR Cash+500bp.
The strategy’s 15-year track record suggests the approach can weather different market cycles, though Schülli acknowledges the strategy requires investors comfortable with interim volatility. “We accept mark-to-market volatility until maturity,” says Schülli. “It’s about high hit-ratios and delivering over annual horizons.”
Whether this patience-based approach can continue delivering as markets evolve and more capital seeks similar opportunities remains an open question. For now, BlueBalance appears content to remain a niche player, hunting dislocations that others either cannot see or cannot afford to wait for.
